Bunkerhill MAC vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Bunkerhill MAC
by Bunkerhill Health
VS
Tempus ECG-AF
by Tempus AI, Inc.

AI Verdict

Bunkerhill MAC and Tempus ECG-AF are adjacent cardiology AI tools, both leveraging FDA-cleared AI for cardiovascular risk identification. Bunkerhill MAC focuses on detecting and quantifying mitral annular calcification from CT scans to aid in general cardiovascular risk assessment. In contrast, Tempus ECG-AF analyzes 12-lead ECGs to predict the risk of new-onset atrial fibrillation in older patients within 12 months, offering a more specific, time-bound risk prediction.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your institution frequently performs routine CT scans and aims to leverage these existing images for proactive cardiovascular risk assessment, specifically for mitral annular calcification. This tool is ideal for identifying patients at increased risk who may otherwise go undetected, enabling early intervention and seamless care coordination through its integration with the Carebricks platform.

View Bunkerhill MAC →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your primary goal is to identify older patients (65+) at elevated risk of developing new-onset atrial fibrillation/flutter within the next year, utilizing standard 12-lead ECG recordings. This solution is particularly well-suited for targeted screening programs in geriatric or internal medicine settings to facilitate earlier follow-up and management of AF risk.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill MAC Tempus ECG-AF
Pricing Unknown Contact vendor
Deployment Cloud-based, integrates with EHRs. Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill MAC

Tool A, Bunkerhill MAC, integrates seamlessly with existing EHRs and clinical systems via the Carebricks platform, and explicitly mentions supporting automated workflows for follow-up and care coordination. This suggests a more comprehensive and potentially more intuitive user experience that extends beyond mere detection to actionable clinical reasoning.

Clinical Value

Tie

Both tools are FDA-cleared and address significant cardiovascular risks. Tool A identifies and quantifies mitral annular calcification (MAC) from routine CT scans, extracting novel insights from existing data. Tool B identifies patients at risk for atrial fibrillation (AF) from ECGs, targeting a prevalent condition in a high-risk demographic. Both offer substantial and distinct clinical value.

Pricing & Value

Tempus ECG-AF

Tool B, Tempus ECG-AF, clearly states that CMS reimbursement is available with specific CPT codes and a Medicare rate, providing a transparent and established path for financial viability for healthcare providers. Tool A only states 'contact for pricing' with no public reimbursement information, making its value proposition less clear from a financial perspective.

Enterprise Readiness

Tempus ECG-AF

Tool B explicitly confirms 'yes' for both BAA (Business Associate Agreement) and HIPAA compliance, which are critical requirements for enterprise adoption and data security in healthcare. Tool A states these are 'likely, but not explicitly stated,' which presents a less definitive stance for organizational compliance and legal teams.

Innovation

Bunkerhill MAC

Tool A, Bunkerhill MAC, explicitly leverages 'Generative AI for clinical reasoning and action' and integrates with the Carebricks platform. Its ability to detect and quantify MAC from routine, non-gated chest CT scans, often performed for other reasons, demonstrates an innovative approach to extracting new, actionable insights from existing data sources.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details regarding the availability, scope, or quality of support and documentation for either Bunkerhill MAC or Tempus ECG-AF. Without this information, it is not possible to definitively distinguish between the two tools in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill MAC Tempus ECG-AF
Name Bunkerhill MAC Tempus ECG-AF
Company Bunkerhill Health Tempus AI, Inc.
Primary Function/Detection Target Detects and quantifies mitral annular calcification (MAC) Identifies patients at increased risk of developing atrial fibrillation/flutter (AF) within 12 months
Input Data Analyzed Routine, non-gated chest CT scans 12-lead ECG recordings
Target Patient Population Patients at increased cardiovascular risk Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill MAC is an FDA-cleared AI algorithm that detects and quantifies mitral annular calcification (MAC) on routine CT scans, which aids in early cardiovascular risk identification. Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Bunkerhill MAC analyzes routine, non-gated chest CT scans. Tempus ECG-AF analyzes 12-lead ECG recordings.
Bunkerhill MAC analyzes routine CT scans, which can be for various indications. Tempus ECG-AF is intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
Bunkerhill MAC is cloud-based and integrates with existing EHRs and clinical systems via the Carebricks platform, which supports automated workflows for follow-up and care coordination. Tempus ECG-AF is a software solution integrated into healthcare facility systems with advanced cardiology algorithms and is designed to work with existing ECG platforms and EHRs.
For Bunkerhill MAC, reimbursement information is not explicitly stated in the provided facts, though Bunkerhill Health has secured CMS reimbursement pathways for other AI cardiovascular analyses. For Tempus ECG-AF, CMS reimbursement is available with CPT codes 0764T and 0765T to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025.
Bunkerhill MAC aids early cardiovascular risk identification and care coordination within the Carebricks platform, by identifying and quantifying MAC on routine CT scans. Tempus ECG-AF supports earlier identification and follow-up for patients at increased risk of developing new-onset Atrial Fibrillation/flutter within 12 months.
Bunkerhill MAC was developed and validated through a multi-institutional research consortium. Tempus ECG-AF was trained on over 1.5 million ECGs from over 500,000 patients.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Bunkerhill MAC or Tempus ECG-AF

Backers

Who funded each tool's parent company.

Tempus ECG-AF

AI Tool Finder
AI-powered search. Results may not be comprehensive.